ilmscore | TOP 5 STOCKS TO WATCH THIS WEEK BEFORE INFLATION REPORT!

Predictions from this Video

Total: 6
Correct: 0
Incorrect: 0
Pending: 6
Prediction
Topic
Status
TEM stock, being overbought, is predicted to retrace after reaching high levels, following its historical pattern of pumping and dumping, and not holding highs for long periods.
"I think that it's pretty safe to say it's overbought and it tends to retrace after reaching these levels. Sure, it could push up to maybe $80. It could push up maybe to 90. It just doesn't hold at these levels for a long period of time. It pumps and then it dumps. It pumps and then it dumps. It pumps and then it dumps. It's no different, right? It rallies and then sells off."
TEM
Pending
Robinhood (HOOD) is predicted to experience incredibly bullish sentiment and further positive catalysts in the short term due to its S&P 500 inclusion, with other funds likely loading up on the stock.
"So, they will also most likely be loading up on Robin Hood as well, which should act as a further positive catalyst. I just think it's important to note that. So, in the short term, at least as of right now, because it's very relevant, it is incredibly bullish news for Robin Hood."
HOOD
Pending
If bullish market conditions return with Fed rate cuts, HIMS, currently oversold at $40, could rally to retest $70 per share.
"It's testing that support range at $40 per share where it is oversold enough that again if conditions do become incredibly bullish again as the Federal Reserve is set to cut rates, if the market goes into a rally breakout all over again. That could allow him to continue to push up. We need to acknowledge that it is oversold enough that people can buy it up and it can go back up to retest $70 per share."
HIMS
Pending
SoFi (SOFI) has retracement potential down to its common support range of $24 per share from its current resistance.
"It's testing up previous resistance range. There's some retracement potential back down to $24 per share, which is a common support range."
SOFI
Pending
UnitedHealth Group (UNH) is not expected to recover anytime soon, with potential for further decline if the ongoing investigation worsens, or recovery if it tapers off. It's viewed as a long-term play without immediate profit expectations.
"I don't expect it to recover anytime soon. I think more bad news can get factored in because of its current investigation. I think things can get worse before they get better... I believe that it will most likely do that until a more clear sense of direction is given to us by the investigation. If the investigation gets worse, I think it could go lower. If the investigation begins to taper off, then maybe we can actually begin to recover."
UNH
Pending
Opendoor (OPEN), being overbought, is predicted to aggressively retrace and pull back hard, continuing its historical pattern after rallies.
"I think that just as quick as it rallied, it has shown that it could aggressively retrace... this thing does have a history of pulling back hard multiple different times even after it rallies."
OPEN
Pending